1,2,4-Triazolo[4,3-a]quinoxaline-1,4-diones as antiallergic agents. 1985

B Loev, and J H Musser, and R E Brown, and H Jones, and R Kahen, and F C Huang, and A Khandwala, and P Sonnino-Goldman, and M J Leibowitz

A series of new 1,4-dihydro-1,2,4-triazolo[4,3-]quinoxaline-1,4-diones has been prepared. These compounds were tested as inhibitors of antigen-induced release of histamine (AIR) in vitro from rat peritoneal mast cells (RMC) and as inhibitors of IgE-mediated rat passive cutaneous anaphylaxis (PCA). Most of this new class of antiallergic agents showed good activity in the RMC and PCA tests. The most potent compound, 2-acetyl-7-chloro-5-n-propyl-1,2,4-triazolo[4,3-a]quinoxaline-1,4-dione (1x), with an I50 value of 0.1 microM, is 30 times more potent than disodium cromoglycate (DSCG) in the RMC assay.

UI MeSH Term Description Entries
D006967 Hypersensitivity Altered reactivity to an antigen, which can result in pathologic reactions upon subsequent exposure to that particular antigen. Allergy,Allergic Reaction,Allergic Reactions,Allergies,Hypersensitivities,Reaction, Allergic,Reactions, Allergic
D008297 Male Males
D010323 Passive Cutaneous Anaphylaxis An evanescent cutaneous reaction occurring when antibody is injected into a local area on the skin and antigen is subsequently injected intravenously along with a dye. The dye makes the rapidly occurring capillary dilatation and increased vascular permeability readily visible by leakage into the reaction site. PCA is a sensitive reaction for detecting very small quantities of antibodies and is also a method for studying the mechanisms of immediate hypersensitivity. Anaphylaxis, Passive Cutaneous,PCA,Cutaneous Anaphylaxis, Passive
D011810 Quinoxalines Quinoxaline
D011919 Rats, Inbred Strains Genetically identical individuals developed from brother and sister matings which have been carried out for twenty or more generations or by parent x offspring matings carried out with certain restrictions. This also includes animals with a long history of closed colony breeding. August Rats,Inbred Rat Strains,Inbred Strain of Rat,Inbred Strain of Rats,Inbred Strains of Rats,Rat, Inbred Strain,August Rat,Inbred Rat Strain,Inbred Strain Rat,Inbred Strain Rats,Inbred Strains Rat,Inbred Strains Rats,Rat Inbred Strain,Rat Inbred Strains,Rat Strain, Inbred,Rat Strains, Inbred,Rat, August,Rat, Inbred Strains,Rats Inbred Strain,Rats Inbred Strains,Rats, August,Rats, Inbred Strain,Strain Rat, Inbred,Strain Rats, Inbred,Strain, Inbred Rat,Strains, Inbred Rat
D006634 Histamine H1 Antagonists Drugs that selectively bind to but do not activate histamine H1 receptors, thereby blocking the actions of endogenous histamine. Included here are the classical antihistaminics that antagonize or prevent the action of histamine mainly in immediate hypersensitivity. They act in the bronchi, capillaries, and some other smooth muscles, and are used to prevent or allay motion sickness, seasonal rhinitis, and allergic dermatitis and to induce somnolence. The effects of blocking central nervous system H1 receptors are not as well understood. Antihistamines, Classical,Antihistaminics, Classical,Antihistaminics, H1,Histamine H1 Antagonist,Histamine H1 Receptor Antagonist,Histamine H1 Receptor Antagonists,Histamine H1 Receptor Blockaders,Antagonists, Histamine H1,Antagonists, Histamine H1 Receptor,Antihistamines, Sedating,Blockaders, Histamine H1 Receptor,First Generation H1 Antagonists,H1 Receptor Blockaders,Histamine H1 Blockers,Receptor Blockaders, H1,Antagonist, Histamine H1,Classical Antihistamines,Classical Antihistaminics,H1 Antagonist, Histamine,H1 Antagonists, Histamine,H1 Antihistaminics,Sedating Antihistamines
D006636 Histamine Release The secretion of histamine from mast cell and basophil granules by exocytosis. This can be initiated by a number of factors, all of which involve binding of IgE, cross-linked by antigen, to the mast cell or basophil's Fc receptors. Once released, histamine binds to a number of different target cell receptors and exerts a wide variety of effects. Histamine Liberation,Histamine Liberations,Histamine Releases
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D014230 Triazoles Heterocyclic compounds containing a five-membered ring with two carbon atoms and three nitrogen atoms with the molecular formula C2H3N3. Triazole

Related Publications

B Loev, and J H Musser, and R E Brown, and H Jones, and R Kahen, and F C Huang, and A Khandwala, and P Sonnino-Goldman, and M J Leibowitz
January 1985, Journal of medicinal chemistry,
B Loev, and J H Musser, and R E Brown, and H Jones, and R Kahen, and F C Huang, and A Khandwala, and P Sonnino-Goldman, and M J Leibowitz
January 2013, ISRN organic chemistry,
B Loev, and J H Musser, and R E Brown, and H Jones, and R Kahen, and F C Huang, and A Khandwala, and P Sonnino-Goldman, and M J Leibowitz
November 2020, Bioorganic chemistry,
B Loev, and J H Musser, and R E Brown, and H Jones, and R Kahen, and F C Huang, and A Khandwala, and P Sonnino-Goldman, and M J Leibowitz
February 2021, Antimicrobial agents and chemotherapy,
B Loev, and J H Musser, and R E Brown, and H Jones, and R Kahen, and F C Huang, and A Khandwala, and P Sonnino-Goldman, and M J Leibowitz
August 2022, Molecular diversity,
B Loev, and J H Musser, and R E Brown, and H Jones, and R Kahen, and F C Huang, and A Khandwala, and P Sonnino-Goldman, and M J Leibowitz
October 2017, Bioorganic & medicinal chemistry letters,
B Loev, and J H Musser, and R E Brown, and H Jones, and R Kahen, and F C Huang, and A Khandwala, and P Sonnino-Goldman, and M J Leibowitz
November 1999, Die Pharmazie,
B Loev, and J H Musser, and R E Brown, and H Jones, and R Kahen, and F C Huang, and A Khandwala, and P Sonnino-Goldman, and M J Leibowitz
May 2003, European journal of medicinal chemistry,
B Loev, and J H Musser, and R E Brown, and H Jones, and R Kahen, and F C Huang, and A Khandwala, and P Sonnino-Goldman, and M J Leibowitz
November 1977, Die Pharmazie,
B Loev, and J H Musser, and R E Brown, and H Jones, and R Kahen, and F C Huang, and A Khandwala, and P Sonnino-Goldman, and M J Leibowitz
March 2009, European journal of medicinal chemistry,
Copied contents to your clipboard!